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1. Introduction 
fl-Lipotropin @-LPH) was originally isolated from 
ovine pituitary extracts in 1965 [l]. fl-LPH aroused 
much interest as it was shown to serve as a precursor 
for pituitary peptides with opiate activity [2]. The 
primary structure of rat fl-LPH has been deduced from 
the nucleotide sequence of a rat pituitary pro-opio- 
melanocortin gene [3]. Studies with purified rat 
pituitary /3-LPH however, have given contradictory 
results concerning the amino acid composition and 
size of the polypeptide [4-61. 
When trying to develop efficient methods for the 
purification of pendorphin/ACTH related peptides 
from the pituitary we noticed that immunoreactive 
/3-LPH from rat pituitary separated into two immuno- 
logically indistinguishable components by cation- 
exchange chromatography. These components are 
stable in concentrated urea solution, have M, 
8000-l 0 500 as assessed by polyacrylamide gel elec- 
trophoresis and gel filtration, and most likely do not 
represent artefactually generated deamidation forms 
of a single fl-LPH molecule. 
10% HOAc and applied into a 2.6 X 90 cm column of 
Sephadex G-75 (Pharmacia) eluted with 10% HOAc 
at 40 ml/h. Fractions of 5.4 ml were collected and 
10 d from each fraction was lyophilized for /3-LPH 
radioimmunoassay [7]. The peak of immunoreactivity 
corresponding to the elution of human @LPH marker 
was divided into 2 pools, a and b (see fig.1). Both 
pools were lyophilized, dissolved in 10 ml 1 mM HCl 
and loaded into columns (0.7 X 18 cm) packed with 
SP-Sephadex C-25 (Pharmacia). Stepwise salt gradient 
at pH 6.7 with or without 6.5 M urea was run as fol- 
lows: wash with 0.05 M NH40Ac until 18 fractions 
of 1.8 ml were eluted. The eluant was changed to 
0.15 M NH40Ac and 27 fractions were collected, 
followed by 0.40 M NH40Ac for 20 fractions and 
finally 1 .O M NH40Ac for 18 fractions. fl-LPH radio- 
immunoassay was performed with eluate diluted 
300 times. Fractions corresponding to the 2 major 
peaks of immunoreactivity (designed as pools 1 and 
2, see fig.2) were pooled, divided into aliquots, lyoph- 
ilized and stored at -20°C. 
There are at least 2 pro-opiomelanocortin genes in 
the rat [3]. Here, we provide evidence which indicates 
that a difference between these genes resides in the 
part coding for fl-LPH. 
2. Materials and methods 
Sixty-eight Sprague-Dawley rats aged 5-l 5 days 
were sacrificed by decapitation. Pituitary glands were 
removed, weighed and immediately extracted with 
10 vol. 0.2 M HCl by sonication [7]. 
The freeze-dried extract was dissolved in 7.5 ml 
Polyacrylamide gel electrophoresis in the presence 
of sodium dodecyl sulfate (SDS-PAGE) was per- 
formed in 12.5% gels according to [ 81. The gels were 
sliced and prepared for radioimmunoassay as in [9]. 
Gel filtration on Sephadex G-75 (0.7 X 49 cm col- 
umns) in the presence of urea was performed as in [ 71. 
For /3-LPH radioimmunoassays [7] 4 different 
antisera were used each directed to the C-terminal 
part of @-LPH and thus crossreacting equimolarly with 
P-endorphin and pro-opiomelanocortin [7,10,11]. 
Dansylation of standard amino acids (Merck) was 
performed according to [ 121. The dansylated amino 
acids were separated by reverse-phase, high-perfor- 
mance liquid chromatography (HPLC, Spherisorb 
5 pm, 4.5 X 250 mm column from Phase Separations) 
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using a Varian model 5000 liquid chromatograph. 
The column was eluted with a linear gradient from 
12-16% 2-propanol in 10 mM NH40Ac (pH 4.00) 
(adjusted with HOAc) during 10 min with a flow rate 
of 1 ml/mm at 38°C. Fluorescence detection was used 
(Varian Fluorichrom, excitation at 340-380 nm, 
emission at 460 nm). 
All chemicals used were purchased from Merck or 
Serva and were of analytical grade. 
3. Results and discussion 
Acid extract of 68 rat pituitaries yielded 16 nmol 
fl-LPH immunoreactivity against porcine flendorphin 
standard. Gel filtration on Sephadex G-75 separated 
the immunoreactivity into 3 components, of which 
the middle one eluted at the same position as human 
&LPH (fig.1). This peak (fractions 37-46 in fig.1, 
3 nmol) was divided into 2 pools, a and b, and they 
were analyzed separately on SP C-25 columns. The 
elution profiles thus obtained are depicted in fig.2. 
Two major peaks of immunoreactivity were detected 
both for pools a and b, the sizes of which varied so 
that the early eluting (more acidic) material (desig- 
nated as pool 1) was detected in greater amounts in 
pool a from G-75 chromatography. The relative sizes 
of components 1and 2 remained unchanged when 
the SP C-25 chromatography was run in the presence 
of 6.5 M urea. Moreover, it was found that compo- 
nent 1 could be eluted with 0.10 M NbOAc while 
component 2eluted with 0.40 M NH40Ac as in the 
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Fig.1. Gel filtration of an acid extract of 68 rat pituitaries on 
a 2.6 X 90 cm Sephadex G-75 column. Aliquots of each frac- 
tion (5.4 ml) were assayed for @-LPH immunoreactivity (col- 
umns). Arrows indicate the elution positions of purified 
human p-LPH [ 141 and synthetic porcine p-endorphin (B-EP) 
1151. 
earlier uns (not shown). The fact that component a, 
which consisted of material from the ascending limb 
of the fl-LPH peak in gel filtration (fig.l), contained 
more immunoreactive material eluting with 0.15 M 
NH40Ac in SP C-25 chromatography suggested that 
there could be a difference in the M,-values of the 
2 components of fl-LPH. However, both compo- 
nents migrated identically in SDS-PAGE in the 
9000-10 5OOM, region (fig.3) and no significant 
difference in the M,-values was detected by gel filtra- 
tion on G-75 in acid urea buffer (figA). Taking into 
account he sensitivity and accuracy of the methods 
used for M, determination we conclude that both 
components have &I, 8000-10 500, and that the M,- 
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Fig.2. Cationexchange chromatography on SP-Sephadex C-25 columns (0.7 X 18 cm) of pools a (left) and b (right) from G-75 
chromatography. Aliquots of the fractions (1.8 ml) were assayed in @-LPH radioimmunoassay (columns). Arrows indicate the 
steps in the salt gradient. For further details see text. 
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Fig.3. SDS-PAGE in 12.5%.acrylamide gels of Mr marker 
peptides (top) and pools 1 (middle) and 2 (bottom) from SP 
C-25 chromatography. 
values of the 2 forms may differ from each other up 
to 15004. 
Immunological characteristics of the 2 forms of 
/3-LPH were studied by subjecting serial dilutions of 
components 1 and 2 to /3-LPH radioimmunoassay 
using 4 different antisera (RB 100, Bendo 2, K 2 and 
K 3; [7,10,11]). Both components were found to 
displace, in parallel, tracer from each of antisera com- 
pared to synthetic porcine flendorphin used as stan- 
dard (not shown). This indicates that both compo- 
nents 1 and 2 contain identical antigenic structures as 
porcine &endorphin (i.e., P-LPH 61-91). Therefore, 
the differences in components 1 and 2 most probably 
reside in the N-terminal part of rat 0.LPH. It was in 
the N-terminal portion that the controversy of the 
structure of rat /I-LPH was located in the earlier stud- 
ies [4-61. In [4] a molecule of -90 amino acids was 
isolated with 2 methionines in its structure, while in 
-flJBE NO. TUBE NO 
Fig.4. Gel filtration of pools 1 (left) and 2 (right) on 0.7 X 
49 cm Sephadex G-75 columns equilibrated and eluted with 
6.5 M urea/O.05 M HCl. Trace quantities of blue dextran, 
12%labelled p-endorphin and lzsI- were run as internal stan- 
dards (arrows). The fractions (0.4 ml) were assayed in P-LPH 
radioimmunoassays (columns). As determined in separate 
runs, purified human fi-LPH (M, 11 700) eluted in fractions 
19-20 and synthetic human ACTH (M, 4500) in fractions 
27 -28. 
[5,6] a molecule with only 1 methionine and 
-70 amino acids total was found. Rat tissues contain 
at least 2 different genes for pro-opiomelanocortin 
(from which /I-LPH is cleaved) thus giving rise to pep- 
tides differing in their ammo acid sequences [3,13]. It 
was speculated [ 131 that one possible site of divergence 
in the different pro-opiomelanocortins might be the 
i 
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Fig.5. HPLC of dansyl derivatives of asparagine (N), gluta- 
mine (Q), aspartic acid (D) and glutamic acid (E). Profile to 
the left shows the elution of standard N, Q, D and E without 
pretreatment. Profile to the right shows the elution of N and 
Q after treatment with HCl, HOAc and NH,OAc identical to 
that of pituitary fl-LPH in section 2; -500 pmol of each 
amino acid was injected to the column. Fluorescent material 
eluting during the first 5 min represents by-products of excess 
dansylC1 reagent. 
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N-terminal portion of /3-LPH, submitted to consider- 
able evolutionary drift. These findings provide evi- 
dence supporting this speculation. We have not 
observed heterogeneity inP-LPH prepared from human 
autopsy pituitaries by methods identical to those 
used here (unpublished). 
Partial deamidation of glutaminyl or asparaginyl 
residues appeared to be the only reasonable possibility 
which could explain the clear difference in charge 
that was observed. Control experiments, however, in 
which we treated glutamine and asparagine in the 
same way as the immunoreactive material showed that 
no detectable conversion of glutamine or asparagine 
to glutamic acid or aspartic acid, respectively, takes 
place in the extraction and chromatography condi- 
tions employed (fig.5). This finding makes most 
unlikely the possibility that the observed charge heter- 
ogeneity of rat fl-LPH is due to artefactual deamidation 
during the purification of the immunoreactive mate- 
rial. 
These results indicate that rat pituitary contains 
2 different forms of /3-LPH differing from each other 
by charge and possibly by size. This paper also presents 
a simple method for separating these 2 forms, which 
will be useful in the isolation of the different P-LPHs. 
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